North American Fetal Therapy Network: Maternal Outcomes in Fetal Aqueductal Stenosis

dc.contributor.authorEmery, Stephen P.
dc.contributor.authorLopa, Samia
dc.contributor.authorPeterson, Erika
dc.contributor.authorMiller, Jena L.
dc.contributor.authorTreadwell, Marjorie C.
dc.contributor.authorGebb, Juliana
dc.contributor.authorGalan, Henry
dc.contributor.authorBergh, Eric P.
dc.contributor.authorCriebaum, Amanda
dc.contributor.authorMcLennan, Amelia
dc.contributor.authorLillegard, Joseph B.
dc.contributor.authorBlumenfeld, Yair J.
dc.contributor.authorTuran, Ozhan M.
dc.contributor.authorStreitman, David C.
dc.contributor.departmentObstetrics and Gynecology, School of Medicine
dc.date.accessioned2025-01-28T10:00:23Z
dc.date.available2025-01-28T10:00:23Z
dc.date.issued2024
dc.description.abstractIntroduction: Fetal aqueductal stenosis (AS) affects approximately 1:1,000 pregnancies. Obstruction of cerebral spinal fluid circulation occurs at the aqueduct of Sylvius, leading to progressive hydrocephalus and macrocephaly, which often necessitates cesarean section (CS). The purpose of this study was to describe maternal outcomes associated with fetal AS. Methods: This study is conducted through the North American Fetal Therapy Network (NAFTNet). Subjects with a prenatal diagnosis of severe fetal central nervous system ventriculomegaly were recruited and followed longitudinally. Maternal events around the delivery of fetuses with AS were recorded and analyzed. Results: Thirty-seven subjects with fetal AS confirmed by neonatal neuroimaging were analyzed. The average gestational age at delivery was 36.7 weeks. Overall, 86% were delivered by CS, and 62% of these were elective. Ninety-one percent of CSs were performed through a Pfannenstiel abdominal incision. A classical uterine incision was required in 13% of cesarean deliveries. The peripartum complication rate was 27%. Conclusion: Women carrying a fetus with AS were at risk for preterm birth, cesarean delivery, a classical uterine incision, and peripartum complications. These data highlight the maternal morbidity associated with fetal AS and the potential benefit of in utero therapy not only for neonatal outcomes but also for maternal outcomes.
dc.eprint.versionAuthor's manuscript
dc.identifier.citationEmery SP, Lopa S, Peterson E, et al. North American Fetal Therapy Network: Maternal Outcomes in Fetal Aqueductal Stenosis. Fetal Diagn Ther. 2024;51(6):612-616. doi:10.1159/000540196
dc.identifier.urihttps://hdl.handle.net/1805/45526
dc.language.isoen_US
dc.publisherKarger
dc.relation.isversionof10.1159/000540196
dc.relation.journalFetal Diagnosis and Therapy
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectFetal aqueductal stenosis
dc.subjectHydrocephalus
dc.subjectMaternal complications
dc.subjectVentriculomegaly
dc.titleNorth American Fetal Therapy Network: Maternal Outcomes in Fetal Aqueductal Stenosis
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Emery2024North-AAM.pdf
Size:
58.24 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: